Sentinel node biopsy in soft tissue sarcoma subtypes with a high propensity for regional lymphatic spread-results of a large prospective trial

Annals of Oncology

Volumn 24, Issue 5, 2013, Pages 1400-1405

  Andreou, D ^a   Boldt, H ^a   Werner, M ^b   Hamann, C ^c   Pink, D ^d   Tunn, P U ^a  

^a HELIOS KLINIKUM BERLIN BUCH   (Germany)

^b HELIOS KLINIKUM EMIL VON BEHRING   (Germany)

^c UNIVERSITY HOSPITAL CARL GUSTAV CARUS   (Germany)

^d HELIOS Klinikum Bad Saarow   (Germany)

Author keywords

Clear cell sarcoma; Epithelioid sarcoma; Lymph node metastases; Rhabdomyosarcoma; Sentinel node biopsy; Synovial sarcoma

Indexed keywords

ALBUMIN TC 99M; FLUORODEOXYGLUCOSE F 18;

ADULT; AGED; ARTICLE; CANCER MORTALITY; CANCER RECURRENCE; CANCER SURVIVAL; CHILD; CLEAR CELL SARCOMA; CLINICAL EVALUATION; DISTANT METASTASIS; EPITHELIOID SARCOMA; FEMALE; FOLLOW UP; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; LYMPH NODE DISSECTION; LYMPH NODE METASTASIS; LYMPHOSCINTIGRAPHY; MAJOR CLINICAL STUDY; MALE; OVERALL SURVIVAL; PRESCHOOL CHILD; PRIORITY JOURNAL; REGIONAL METASTASIS; RHABDOMYOSARCOMA; SENTINEL LYMPH NODE BIOPSY; SOFT TISSUE SARCOMA; SYNOVIAL SARCOMA;

ADOLESCENT; ADULT; AGED; CHILD; FEMALE; HUMANS; LYMPHATIC METASTASIS; MALE; MIDDLE AGED; PROSPECTIVE STUDIES; RHABDOMYOSARCOMA; SARCOMA, CLEAR CELL; SARCOMA, SYNOVIAL; SENTINEL LYMPH NODE BIOPSY; SOFT TISSUE NEOPLASMS; YOUNG ADULT;

EID: 84877143547     PISSN: 09237534     EISSN: 15698041     Source Type: Journal    
DOI: 10.1093/annonc/mds650     Document Type: Article

References (38)

1. Billingsley KG, Burt ME, Jara E et al. Pulmonary metastases from soft tissue sarcoma: analysis of patterns of diseases and postmetastasis survival. Ann Surg 1999; 229: 602-610; discussion 610-602.
2. Riad S, Griffin AM, Liberman B et al. Lymph node metastasis in soft tissue sarcoma in an extremity. Clin Orthop Relat Res 2004; 426: 129-134.
3. Behranwala KA, A'Hern R, Omar AM et al. Prognosis of lymph node metastasis in soft tissue sarcoma. Ann Surg Oncol 2004; 11: 714-719.
4. Fong Y, Coit DG, Woodruff JM et al. Lymph node metastasis from soft tissue sarcoma in adults. Analysis of data from a prospective database of 1772 sarcoma patients. Ann Surg 1993; 217: 72-77.
5. Weingrad DN, Rosenberg SA. Early lymphatic spread of osteogenic and softtissue sarcomas. Surgery 1978; 84: 231-240.
6. Mazeron JJ, Suit HD. Lymph nodes as sites of metastases from sarcomas of soft tissue. Cancer 1987; 60: 1800-1808.
7. Skinner KA, Eilber FR. Soft tissue sarcoma nodal metastases: biologic significance and therapeutic considerations. Surg Oncol Clin N Am 1996; 5: 121-127.
8. Andreou D, Tunn PU. Sentinel node biopsy in soft tissue sarcoma. Recent Results Cancer Res 2009; 179: 25-36.
9. Neville HL, Andrassy RJ, Lobe TE et al. Preoperative staging, prognostic factors, and outcome for extremity rhabdomyosarcoma: a preliminary report from the Intergroup Rhabdomyosarcoma Study IV (1991-1997). J Pediatr Surg 2000; 35: 317-321.
10. Morton DL, Cochran AJ, Thompson JF et al. Sentinel node biopsy for early-stage melanoma: accuracy and morbidity in MSLT-I, an international multicenter trial. Ann Surg 2005; 242: 302-311; discussion 311-303.
11. Cabanas RM. An approach for the treatment of penile carcinoma. Cancer 1977; 39: 456-466.
12. Morton DL, Wen DR, Wong JH et al. Technical details of intraoperative lymphatic mapping for early stage melanoma. Arch Surg 1992; 127: 392-399.
13. Nieweg OE, Tanis PJ, Kroon BB. The definition of a sentinel node. Ann Surg Oncol 2001; 8: 538-541.
14. Wong SL, Balch CM, Hurley P et al. Sentinel lymph node biopsy for melanoma: American society of clinical oncology and society of surgical oncology joint clinical practice guideline. Ann Surg Oncol 2012; 19: 3313-3324.
15. Cheng G, Kurita S, Torigian DA et al. Current status of sentinel lymph-node biopsy in patients with breast cancer. Eur J Nucl Med Mol Imaging 2011; 38: 562-575.
16. van der Zaag ES, Bouma WH, Tanis PJ et al. Systematic review of sentinel lymph node mapping procedure in colorectal cancer. Ann Surg Oncol 2012; 19: 3449-3459.
17. Balasubramanian SP, Harrison BJ. Systematic review and meta-analysis of sentinel node biopsy in thyroid cancer. Br J Surg 2011; 98: 334-344.
18. Leong SP, Cady B, Jablons DM et al. Clinical patterns of metastasis. Cancer Metastasis Rev 2006; 25: 221-232.
19. Siegel R, Naishadham D, Jemal A. Cancer statistics, 2012. CA Cancer J Clin 2012; 62: 10-29.
20. Javan H, Gholami H, Assadi M et al. The accuracy of sentinel node biopsy in breast cancer patients with the history of previous surgical biopsy of the primary lesion: systematic review and meta-analysis of the literature. Eur J Surg Oncol 2012; 38: 95-109.
21. Rydholm A, Berg NO, Gullberg B et al. Epidemiology of soft-tissue sarcoma in the locomotor system. A retrospective population-based study of the interrelationships between clinical and morphologic variables. Acta Pathol Microbiol Immunol Scand A 1984; 92: 363-374.
22. Wright S, Armeson K, Hill EG et al. The role of sentinel lymph node biopsy in select sarcoma patients: a meta-analysis. Am J Surg 2012; 204: 428-433.
23. Tunn PU, Andreou D, Illing H et al. Sentinel node biopsy in synovial sarcoma. Eur J Surg Oncol 2008; 34: 704-707.
24. McMasters KM, Noyes RD, Reintgen DS et al. Lessons learned from the sunbelt melanoma trial. J Surg Oncol 2004; 86: 212-223.
25. Cook MG, Green MA, Anderson B et al. The development of optimal pathological assessment of sentinel lymph nodes for melanoma. J Pathol 2003; 200: 314-319.
26. Kaplan E, Meier P. Nonparametric estimation from incomplete observations. J Am Stat Assoc 1958; 53: 457-481.
27. Mantel N. Evaluation of survival data and two new rank order statistics arising in its consideration. Cancer Chemother Rep 1966; 50: 163-170.
28. Maduekwe UN, Hornicek FJ, Springfield DS et al. Role of sentinel lymph node biopsy in the staging of synovial, epithelioid, and clear cell sarcomas. Ann Surg Oncol 2009; 16: 1356-1363.
29. Parida L, Morrisson GT, Shammas A et al. Role of lymphoscintigraphy and sentinel lymph node biopsy in the management of pediatric melanoma and sarcoma. Pediatr Surg Int 2012; 28: 571-578.
30. Deenik W, Mooi WJ, Rutgers EJ et al. Clear cell sarcoma (malignant melanoma) of soft parts: a clinicopathologic study of 30 cases. Cancer 1999; 86: 969-975.
31. Kawai A, Hosono A, Nakayama R et al. Clear cell sarcoma of tendons and aponeuroses: a study of 75 patients. Cancer 2007; 109: 109-116.
32. Specht MC, Fey JV, Borgen PI et al. Is the clinically positive axilla in breast cancer really a contraindication to sentinel lymph node biopsy?. J Am Coll Surg 2005; 200: 10-14.
33. Ferrari A, Dileo P, Casanova M et al. Rhabdomyosarcoma in adults. A retrospective analysis of 171 patients treated at a single institution. Cancer 2003; 98: 571-580.
34. Little DJ, Ballo MT, Zagars GK et al. Adult rhabdomyosarcoma: outcome following multimodality treatment. Cancer 2002; 95: 377-388.
35. Sultan I, Qaddoumi I, Yaser S et al. Comparing adult and pediatric rhabdomyosarcoma in the surveillance, epidemiology and end results program, 1973 to 2005: an analysis of 2,600 patients. J Clin Oncol 2009; 27: 3391-3397.
36. Rutkowski P, Nowecki ZI, van Akkooi AC et al. Multimarker reverse transcriptasepolymerase chain reaction assay in lymphatic drainage and sentinel node tumor burden. Ann Surg Oncol 2010; 17: 3314-3323.
37. Krag DN, Anderson SJ, Julian TB et al. Technical outcomes of sentinel-lymphnode resection and conventional axillary-lymph-node dissection in patients with clinically node-negative breast cancer: results from the NSABP B-32 randomised phase III trial. Lancet Oncol 2007; 8: 881-888.
38. Veronesi U, Paganelli G, Viale G et al. A randomized comparison of sentinel-node biopsy with routine axillary dissection in breast cancer. N Engl J Med 2003; 349: 546-553.